An ASCO preview: What to watch for at cancer research’s big meeting
-
By
-
Adam Feuerstein
-
May 28, 2026
By
Adam Feuerstein
May 28, 2026
VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies
July 14, 2026